Jeena Sikho Lifecare Limited — PPTs, 31-05-2026: Investor Presentation

Jeena Sikho Lifecare showed strong Q4FY26 performance with revenue up 55% YoY to ₹215.55 Cr and PAT soaring 79% to ₹45.35 Cr. For FY26, revenue jumped 71% to ₹801.35 Cr, and PAT surged 178% to ₹222.18 Cr, with EPS at ₹17.87. FY26 EBITDA margins improved to a robust 44%.

Growth was driven by a 93% rise in Ayurveda Healthcare Products and solid patient volume increases in services (IPD +65%, OPD +69% for FY26). The company expands via a capital-light, hub-and-spoke model, with 2,300 operational beds out of 2,861 total capacity.

Recent developments include the Jeena Sikho Health Card for patient loyalty and continuous product diversification. Management is confident in sustained growth, fueled by increasing Ayurveda acceptance and strategic expansion. A final dividend of ₹4.50 per share for FY26 was declared.